Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Golka K et al. – The authors analysed a hospital–based case–control series not selected for occupational exposure, rs9642880[T] was influential, in contrast to GSTM1 0/0. However, in a case–control series of patients that have been occupationally exposed to aromatic amines and polycyclic aromatic hydrocarbons, rs9642880[T] was not influential but GSTM1 0/0 was significantly associated with bladder cancer risk. Therefore, the degree to which rs9642880[T] and GSTM1 0/0 confer susceptibility to urinary bladder cancer seems to depend on the extent of exposure to urinary bladder carcinogens.

Related Articles

Increased bladder cancer risk among workers exposed to o-toluidine and aniline: A reanalysis
Occupational and Environmental Medicine, 11/06/09    Relevance Score: 79%

Dermatomyositis and small cell carcinoma of the bladder
Canadian Family Physician, 10/14/09    Relevance Score: 79%

Diagnosis and Treatment of Bladder Cancer
American Family Physician, 10/01/09    Relevance Score: 79%

Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09    Relevance Score: 69%

Fat Within the Wall of the Urinary Bladder: Computed Tomographic Appearance
Journal of Computer Assisted Tomography, 10/12/09    Relevance Score: 69%

Today in Basic Science...keeping you current

Voltage-gated sodium channels in nociception and their potential as targets for new drugs in treatment of chronic neuropathic pain
Current Anaesthesia and Critical Care, 11/24/09

Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study
British Journal of Clinical Pharmacology, 11/24/09

Interactions between morphine and nitric oxide in various organs
Journal of Anesthesia, 11/24/09

Today in Chemotherapy/Oncology...keeping you current

Salvage treatment with upfront melphalan 100 mg/m2 and consolidation with novel drugs for fulminant progression of multiple myeloma
Annals of Hematology, 11/24/09

The rationale for mTOR inhibition in epithelial ovarian cancer
Expert Opinion on Investigational Drugs, 11/24/09

Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia
Archives of Drug Information, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address